SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-010143
Filing Date
2020-02-18
Accepted
2020-02-18 16:30:04
Documents
1
Period of Report
2020-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4249
  Complete submission text file 0001209191-20-010143.txt   5741
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS,INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Shefferman Jesse (Reporting) CIK: 0001799167 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36694 | Film No.: 20625744